Surface Oncology (SURF) Income Statement (2018 - 2023)
Income Statement report data from Jun 30, 2018 to Jun 30, 2023 for Surface Oncology (SURF).
Reported currency: USD
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||
Total Revenue | - | - | - | - | - | 30M (+18650.00%) | 160K (-58.97%) | 390K (-25.00%) | 520K (-68.10%) | 1.63M (-98.14%) | 88M | - | - | 39M (+8670.45%) | 440K (+29.41%) | 340K (+142.86%) | 140K (-99.03%) | 14M (+47.85%) | 9.76M (+464.16%) | 1.73M (-28.81%) | 2.43M |
Gross Profit | - | - | - | - | - | 30M (+18650.00%) | 160K (-58.97%) | 390K (-25.00%) | 520K (-68.10%) | 1.63M (-98.14%) | 88M | - | - | 39M (+8670.45%) | 440K (+29.41%) | 340K (+142.86%) | 140K (-99.03%) | 14M (+47.85%) | 9.76M (+464.16%) | 1.73M (-28.81%) | 2.43M |
Operating Expenses | |||||||||||||||||||||
Research And Development | 14M (+0.36%) | 14M (-9.88%) | 15M (-9.47%) | 17M (-7.20%) | 18M (+9.51%) | 17M (+1.84%) | 16M (+16.24%) | 14M (+10.81%) | 13M (+20.21%) | 11M (-1.77%) | 11M (+13.54%) | 9.45M (-1.05%) | 9.55M (-15.41%) | 11M (-3.17%) | 12M (-9.75%) | 13M (-2.42%) | 13M (-7.48%) | 14M (+36.03%) | 11M (-33.33%) | 16M (+4.50%) | 15M |
Selling General And Administrative | 8.58M (+45.67%) | 5.89M (-0.17%) | 5.90M (-1.67%) | 6.00M (-6.69%) | 6.43M (-1.68%) | 6.54M (-9.29%) | 7.21M (+23.25%) | 5.85M (-9.02%) | 6.43M (+14.01%) | 5.64M (-36.41%) | 8.87M (+81.02%) | 4.90M (-2.00%) | 5.00M (+4.38%) | 4.79M (-6.26%) | 5.11M (+2.61%) | 4.98M (-8.12%) | 5.42M (+6.48%) | 5.09M (+5.60%) | 4.82M (+21.11%) | 3.98M (+1.79%) | 3.91M |
Operating Expenses | 26M (+30.42%) | 20M (-7.18%) | 21M (-7.51%) | 23M (-6.99%) | 25M (+6.30%) | 23M (-1.57%) | 24M (+18.36%) | 20M (+4.08%) | 19M (+18.05%) | 16M (-17.45%) | 20M (+36.49%) | 14M (-1.24%) | 15M (-9.58%) | 16M (-4.11%) | 17M (-6.31%) | 18M (-4.02%) | 19M (-3.87%) | 19M (+26.38%) | 15M (-22.32%) | 20M (+3.95%) | 19M |
Operating Income | |||||||||||||||||||||
Operating Income | -25.64M (+30.42%) | -19.66M (-7.18%) | -21.18M (-7.51%) | -22.90M (-6.99%) | -24.62M | 6.84M | -23.37M (+19.91%) | -19.49M (+4.84%) | -18.59M (+27.68%) | -14.56M | 68M | -14.36M (-1.24%) | -14.54M | 23M | -16.33M (-7.00%) | -17.56M (-5.13%) | -18.51M (+272.43%) | -4.97M (-10.93%) | -5.58M (-69.05%) | -18.03M (+8.75%) | -16.58M |
EBITDA | -20.42M (+5.58%) | -19.34M (-7.24%) | -20.85M (-8.95%) | -22.90M (-5.68%) | -24.28M | 7.18M | -23.00M (+20.42%) | -19.10M (+5.00%) | -18.19M (+28.55%) | -14.15M | 68M | -13.95M (-1.41%) | -14.15M | 23M | -15.87M (-7.19%) | -17.10M (-5.37%) | -18.07M (+298.02%) | -4.54M (-13.03%) | -5.22M (-70.51%) | -17.70M (+8.86%) | -16.26M |
Other Income / Expenses | |||||||||||||||||||||
Interest Expense | -3.11M (+234.41%) | -930.00K (+3.33%) | -900.00K (+8.43%) | -830.00K (+13.70%) | -730.00K (+7.35%) | -680.00K (0.00%) | -680.00K (+61.90%) | -420.00K (0.00%) | -420.00K (-58.82%) | -1.02M (+64.52%) | -620.00K (-57.82%) | -1.47M (+241.86%) | -430.00K (+26.47%) | -340.00K (-85.47%) | -2.34M | 680K (-9.33%) | 750K (-2.60%) | 770K (-9.41%) | 850K (+4.94%) | 810K (+10.96%) | 730K |
Net Interest Income | 3.11M (+234.41%) | 930K (+3.33%) | 900K (+8.43%) | 830K (+13.70%) | 730K (+7.35%) | 680K (-1.45%) | 690K (+64.29%) | 420K (0.00%) | 420K (-58.82%) | 1.02M (+64.52%) | 620K (-57.82%) | 1.47M (+241.86%) | 430K (+26.47%) | 340K (-85.47%) | 2.34M | -680.00K (-9.33%) | -750.00K (-2.60%) | -770.00K (-9.41%) | -850.00K (+4.94%) | -810.00K (+10.96%) | -730.00K |
Other Non Operating Income | 560K (-34.12%) | 850K (+13.33%) | 750K (+53.06%) | 490K (+250.00%) | 140K (+180.00%) | 50K (+400.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (0.00%) | 20K | - | 50K (-68.75%) | 160K (-58.97%) | 390K | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||
Income Before Tax | -28.19M (+42.81%) | -19.74M (-7.45%) | -21.33M (-8.22%) | -23.24M (-7.81%) | -25.21M | 6.20M | -24.05M (+20.92%) | -19.89M (+4.79%) | -18.98M (+21.98%) | -15.56M | 67M | -15.77M (+6.48%) | -14.81M | 23M | -15.95M (-5.51%) | -16.88M (-4.95%) | -17.76M (+322.86%) | -4.20M (-11.39%) | -4.74M (-72.47%) | -17.22M (+8.64%) | -15.85M |
Net Income From Continuing Operations | -28.19M (+42.81%) | -19.74M (-7.45%) | -21.33M (-8.22%) | -23.24M (-7.81%) | -25.21M | 6.20M | -24.05M (+20.92%) | -19.89M (+4.79%) | -18.98M (+21.98%) | -15.56M | 67M | -15.77M (+6.48%) | -14.81M | 23M | -15.95M (-5.51%) | -16.88M (-4.95%) | -17.76M (+322.86%) | -4.20M (-11.39%) | -4.74M (-72.47%) | -17.22M (+8.64%) | -15.85M |
Net Income | -28.19M (+42.81%) | -19.74M (-7.45%) | -21.33M (-8.22%) | -23.24M (-7.81%) | -25.21M | 6.20M | -24.05M (+20.92%) | -19.89M (+4.79%) | -18.98M (+21.98%) | -15.56M | 67M | -15.77M (+6.48%) | -14.81M | 23M | -15.95M (-5.51%) | -16.88M (-4.95%) | -17.76M (+322.86%) | -4.20M (-11.39%) | -4.74M (-72.47%) | -17.22M (+8.64%) | -15.85M |